Código QR

Survey to Specify SGLT2 Inhibitor Choice in T2DM Management

OBJECTIVE: There are no major head-to-head comparative studies till date to compare the differences in glycemic efficacy, safety, or cardio-renal effects within SGLT2 inhibitors. This survey was conducted to understand the different parameters that clinicians identify while choosing an SGLT2 inhibit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Samit Ghosal, Radhika M. Joshi, Rahul N. Iyer, Samir M. Adsule
Formato: Artigo
Idioma:Inglês
Publicado: Via Medica 2022-10-01
Series:Clinical Diabetology
Assuntos:
Acceso en liña:https://journals.viamedica.pl/clinical_diabetology/article/view/87411
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!